Hypoxia Selects for a Quiescent, CML Stem/Leukemia Initiating- Like Population Dependent on CBP/Catenin Transcription

E-ISSN： 1874-4702|6|3|204-210

ISSN： 1874-4672

Source： Current Molecular Pharmacology, Vol.6, Iss.3, 2013-11, pp. : 204-210

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Characterization of Imatinib Resistant CML Leukemic Stem/Initiating Cells and Their Sensitivity to CBP/Catenin Antagonists

Current Molecular Pharmacology, Vol. 11, Iss. 2, 2018-04 ,pp. : 113-121

Bentham Science Publishers

Access to resources Recommend Favorite

CBP-dependent Wnt/&bgr;-catenin signaling is crucial in regulation of MDR1 transcription

Current Cancer Drug Targets, Vol. 15, Iss. 6, 2015-01 ,pp. : 519-532

Bentham Science Publishers

Access to resources Recommend Favorite

The Gamma Catenin/CBP Complex Maintains Survivin Transcription in &bgr;-catenin Deficient/Depleted Cancer Cells

Current Cancer Drug Targets, Vol. 11, Iss. 2, 2011-02 ,pp. : 213-225

Bentham Science Publishers

Access to resources Recommend Favorite

Stem Cell Transplantation for Chronic Myeloid Leukemia (CML): Current Indications and Perspectives

Current Cancer Drug Targets, Vol. 13, Iss. 7, 2013-01 ,pp. : 775-778

Bentham Science Publishers

Access to resources Recommend Favorite

Advances in Immunotherapy of Chronic Myeloid Leukemia CML

Current Cancer Drug Targets, Vol. 13, Iss. 7, 2013-09 ,pp. : 768-774

Bentham Science Publishers

Access to resources Recommend Favorite